Insulet (PODD) Competitors

Becton, Dickinson and Company (NYSE:BDX) and Insulet (NASDAQ:PODD) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Do analysts rate BDX or PODD?

Becton, Dickinson and Company presently has a consensus price target of $219.22, indicating a potential upside of 27.41%. Insulet has a consensus price target of $318.41, indicating a potential upside of 4.52%. Given Becton, Dickinson and Company's higher possible upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	0 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.36
Insulet	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Is BDX or PODD more profitable?

Insulet has a net margin of 20.19% compared to Becton, Dickinson and Company's net margin of 8.47%. Insulet's return on equity of 24.46% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	8.47%	15.74%	7.29%
Insulet	20.19%	24.46%	8.33%

Does the MarketBeat Community believe in BDX or PODD?

Insulet received 135 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.37% of users gave Insulet an outperform vote while only 62.07% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Becton, Dickinson and Company	Outperform Votes 607 62.07%	Underperform Votes 371 37.93%
Insulet	Outperform Votes 742 66.37%	Underperform Votes 376 33.63%

Which has preferable earnings and valuation, BDX or PODD?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$20.87B	2.36	$1.71B	$5.24	32.84
Insulet	$2.20B	9.75	$206.30M	$5.56	54.79

Do insiders and institutionals hold more shares of BDX or PODD?

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.4% of Insulet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more risk and volatility, BDX or PODD?

Becton, Dickinson and Company has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Insulet has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Does the media prefer BDX or PODD?

In the previous week, Becton, Dickinson and Company had 4 more articles in the media than Insulet. MarketBeat recorded 18 mentions for Becton, Dickinson and Company and 14 mentions for Insulet. Becton, Dickinson and Company's average media sentiment score of 1.27 beat Insulet's score of 0.87 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	12 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Insulet	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Insulet beats Becton, Dickinson and Company on 12 of the 18 factors compared between the two stocks.